Global Pancreatic and Biliary Stent Market Projected to Grow at 4.6% CAGR through 2034: Fact.MR Report

Rising use of endoscopic ultrasound for precise stent placement and improved patient outcomes driving demand for pancreatic and biliary stents, says Fact.MR.

ROCKVILLE PIKE SUITE, ROCKVILLE, USA, July 17, 2024 /EINPresswire.com/ --
According to a new industry report by Fact.MR, the global market for pancreatic and biliary stents market is estimated to reach US$ 370.2 million in 2024 and further increase at 4.6% CAGR from 2024 to 2034.

Pancreatic and biliary stents are used to treat pancreatic or biliary leaks or to prevent pancreatitis after endoscopic retrograde cholangiopancreatography (ERCP) surgery. Primary driver for the growth of the pancreatic and biliary stent market is the increasing number of procedures that require stent placement and recurrent stenting. Biliary obstruction conditions are leading to an increase in the need for ERCP treatments, which include stenting.

Get Free Sample Copy of This Report-https://www.factmr.com/connectus/sample?flag=S&rep_id=10117

Patients with conditions that cause biliary obstruction, such as gallstones, biliary strictures, pancreatitis, inflammation of the bile ducts, cysts, trauma, infection, including cirrhosis and hepatitis, and severe liver damage, are generating demand for pancreatic and biliary stents. Pancreatic and biliary stents are used to help drain bile into the digestive tract in a majority of cases of biliary obstruction, biliary fistulas, and biliary strictures.

Key Takeaways from Market Study

The global pancreatic and biliary stent market is projected to expand at a compound annual growth rate (CAGR) of 4.6% from 2024 to 2034, with the market forecasted to reach US$ 583 million by the end of this period. In the United States, the market is set to reach a value of US$ 156 million in 2024. China is estimated to account for 42.1% of the market share in East Asia in the same year. Additionally, revenue from the sales of pancreatic and biliary stents in Japan is set to reach US$ 15 million in 2024. The East Asia market as a whole is forecasted to expand at a CAGR of 3.5% from 2024 to 2034.

“China hosts numerous research and development centers for various pancreatic and biliary stent companies, thereby boosting product sales in the country,” says a Fact.MR analyst.

Hospitals Accounting for Leading Market Share Due to Availability of Advanced Techniques for Accurate Stent Placement

To precisely position stents, some hospitals use endoscopic ultrasound (EUS), which provides detailed images of the bile duct obtained through an endoscope equipped with a small ultrasound probe inserted through the mouth and down the throat. The implementation of this strategic approach ensures that biliary stents are placed accurately and efficiently, improving patient outcomes and enhancing the hospital's capacity to provide comprehensive biliary care services.

Key Companies Profiled-

Abbott Laboratories; Beckton, Dickson and Company; Medtronic Plc.; Olympus Corporation; CONMED Corporation; Boston Scientific Corporation; Cook Medical Inc.; Merit Medical System; Cardinal Health.

More Valuable Insights on Offer

Fact.MR, in its new offering, presents an unbiased analysis of the pancreatic and biliary stent market for 2019 to 2023 and forecast statistics for 2024 to 2034.

The study divulges the pancreatic and biliary stent market based on product type (plastic, metal), application (benign biliary strictures, biliary leaks, malignant obstruction, biliary stones, pancreatic cancer), and end use (hospitals, ambulatory surgical centers, specialty clinics), across seven major regions of the world (North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia & Pacific, and MEA).

Get Customization on this Report for Specific Research Solutions: https://www.factmr.com/connectus/sample?flag=S&rep_id=10117

Explore More Related Studies Published by Fact.MR Research:

Medical Device Complaint Management Market-The medical device complaint management market is expected to garner a market value of US$ 5.35 Bn in 2022, anticipated to register a positive CAGR of 7% in the forecast period 2022-2032 and reach a value of US$ 10.52 Bn.

Veterinary Hematology Analyzers Market-The global veterinary hematology analyzers market is valued at US$ 971.6 million in 2023 and is expected to increase at a CAGR of 5% to reach US$ 1.58 billion by the end of 2033.

About Fact.MR:

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client’s satisfaction.

Contact:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232 (D)
Sales Team: sales@factmr.com

Akshay Gorde
FactMR
email us here